Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1-2
pubmed:dateCreated
2011-1-6
pubmed:abstractText
To explore the effect of LYRM1 over-expression on basal and insulin-stimulated glucose uptake in rat skeletal muscle cells, and to understand the underlying mechanisms, Rat myoblasts (L6) transfected with either an empty expression vector (pcDNA3.1Myc/His B) or a LYRM1 expression vector were differentiated into myotubes. Glucose uptake was determined by measuring 2-deoxy-D-[(3)H] glucose uptake into L6 myotubes. Western blotting was performed to assess the translocation of insulin-sensitive glucose transporter 4 (GLUT4). It was also used to measure the phosphorylation and total protein contents of insulin-signaling proteins, such as the insulin receptor (IR), insulin receptor substrate (IRS)-1, phosphatidylinositol-3-kinase (PI3K) p85, Akt, ERK1/2, P38, and JNK. LYRM1 over-expression in L6 myotubes reduced insulin-stimulated glucose uptake and impaired insulin-stimulated GLUT4 translocation. It also diminished insulin-stimulated tyrosine phosphorylation of IRS-1, PI3K (p85), and serine phosphorylation of Akt without affecting the phosphorylation of IR, ERK1/2, P38, and JNK. LYRM1 regulates the function of IRS-1, PI3K, and Akt, and decreases GLUT4 translocation and glucose uptake in response to insulin. These observations highlight the potential role of LYRM1 in glucose homeostasis and possibly in the pathophysiology of type 2 diabetes related to obesity.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
1573-4919
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
348
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
149-54
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:21072680-Animals, pubmed-meshheading:21072680-Apoptosis Regulatory Proteins, pubmed-meshheading:21072680-Biological Transport, pubmed-meshheading:21072680-Blotting, Western, pubmed-meshheading:21072680-Cell Line, pubmed-meshheading:21072680-Deoxyglucose, pubmed-meshheading:21072680-Down-Regulation, pubmed-meshheading:21072680-Glucose Transporter Type 4, pubmed-meshheading:21072680-Insulin, pubmed-meshheading:21072680-Insulin Receptor Substrate Proteins, pubmed-meshheading:21072680-Muscle Fibers, Skeletal, pubmed-meshheading:21072680-Myoblasts, Skeletal, pubmed-meshheading:21072680-Phosphatidylinositol 3-Kinase, pubmed-meshheading:21072680-Phosphorylation, pubmed-meshheading:21072680-Protein Transport, pubmed-meshheading:21072680-Proto-Oncogene Proteins c-akt, pubmed-meshheading:21072680-Rats, pubmed-meshheading:21072680-Signal Transduction, pubmed-meshheading:21072680-Transfection, pubmed-meshheading:21072680-Up-Regulation
pubmed:year
2011
pubmed:articleTitle
Over-expression of LYRM1 inhibits glucose transport in rat skeletal muscles via attenuated phosphorylation of PI3K (p85) and Akt.
pubmed:affiliation
Department of Pediatrics, Nanjing Maternal and Child Health Hospital of Nanjing Medical University, Nanjing, China.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't